Universe Pharmaceuticals Inc (UPC): EPS (Basic)

Annual figures by period end, from SEC filings.

Figures out of scale. In this company's filings, reported revenue for the year ended 2023-09-30 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.

Stock splits: 1-for-6, first reflected in a filing dated 2023-08-31. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

-$8.06
Year ended 2025-09-30. As filed; likely tagged in the wrong unit
$3.582020-09-30: $0.472021-09-30: $3.582022-09-30: -$1309.112023-09-30: -$1089.212024-09-30: -$626.962025-09-30: -$8.06-$8.06
2020-09-30 EPS (Basic) (USD per share) 2025-09-30

Paler bars were last filed before a stock split, on the old share basis.

Period endedEPS (Basic)Change YoYSource filing
2025-09-30-$8.06n/a2026-01-29, From 2024-10-01
2024-09-30-$626.96n/a2026-01-29, From 2023-10-01
2023-09-30-$1089.21n/a2026-01-29, From 2022-10-01
2022-09-30-$1309.11n/a2025-04-29, From 2021-10-01
2021-09-30$3.58n/a2024-01-30, From 2020-10-01
2020-09-30$0.47n/a2023-02-10, From 2019-10-01